XML 27 R16.htm IDEA: XBRL DOCUMENT
v3.25.3

Equity | 9 Months Ended
--- | ---
Nov. 01, 2025
Equity [Abstract] |
Equity | Equity There were 358,191,765, 218,812,292, and zero shares of Class A, Class B, and Class C common stock, respectively, issued and outstanding as of November 1, 2025. There were 295,839,286, 269,879,953, and zero shares of Class A, Class B, and Class C common stock, respectively, issued and outstanding as of February 1, 2025. The Company had reserved shares of common stock for future issuance as of November 1, 2025 and February 1, 2025, as follows:
| As of
| November 1, 2025 |  | February 1, 2025
2015 Equity Incentive Plan: |  |  |
Options outstanding | 5,572,614 |  |  | 5,632,520 |
RSUs outstanding | 52 |  |  | 790,123 |
2021 Equity Incentive Plan: |  |  |
RSUs outstanding | 17,719,356 |  |  | 21,520,741 |
Shares available for future grants | 112,754,217 |  |  | 90,518,967 |
2021 Employee Stock Purchase Plan: |  |  |
Shares available for future issuance | 26,358,940 |  |  | 21,284,493 |
Total shares of common stock reserved for future issuance | 162,405,179 |  |  | 139,746,844 |
Employee Compensation Plans The Company currently has two equity incentive plans, the 2015 Equity Incentive Plan (the “2015 Plan”) and the 2021 Equity Incentive Plan (the “2021 Plan”). The 2015 Plan was terminated in connection with the adoption of the 2021 Plan in December 2021 but continues to govern the terms of outstanding stock options and RSUs that were granted prior to the termination of the 2015 Plan. The Company no longer grants equity awards pursuant to the 2015 Plan. 2021 Equity Incentive Plan—In December 2021, the Board of Directors adopted and stockholders approved the 2021 Plan, which became effective in December 2021 in connection with the Company’s initial public offering (“IPO”). The total number of shares of the Company’s Class A common stock reserved for future grants as of November 1, 2025 includes 28,285,961 shares added on the first day of fiscal ye a r 2026 pursuant to the annual automatic evergreen increase provision of the 2021 Plan. Options—A summary of the stock options activity under the 2015 Plan during the nine months ended November 1, 2025 is presented below (the number of options represents shares of common stock exercisable in respect thereof):
| Number of Shares |  | Weighted-Average Exercise Price |  | Weighted-Average Remaining Contractual Term (in years) |  | Aggregate Intrinsic Value (1) (in thousands)
Balance as of February 1, 2025 | 5,632,520 |  |  | $ | 5.40 |  |  | 4.9 |  | $ | 259,635 |
Granted | — |  |  | $ | — |  |  |  |  |
Exercised | (59,906) |  |  | $ | 0.58 |  |  |  |  |
Forfeited, canceled, or expired | — |  |  | $ | — |  |  |  |  |
Balance as of November 1, 2025 | 5,572,614 |  |  | $ | 5.45 |  |  | 4.1 |  | $ | 193,447 |
Exercisable as of November 1, 2025 | 5,572,614 |  |  | $ | 5.45 |  |  | 4.1 |  | $ | 193,447 |
__________ (1)Aggregate intrinsic value for stock options represents the difference between the exercise price and the per share fair value of the Company’s Class A common stock for each period end presented, multiplied by the number of stock options outstanding or exercisable as of each period end presented. The intrinsic value of stock options exercised was $2.2 million and $21.0 million during the nine months ended November 1, 2025 and November 2, 2024, respectively. As of November 1, 2025, the Company had no remaining unrecognized stock-based compensation expense related to outstanding stock options. RSUs—RSUs granted prior to the IPO had both a service condition and a performance condition (defined under the 2015 Plan as the occurrence of a qualifying liquidity event, which was defined as the earlier of a successful IPO or acquisition). Stock-based compensation expense was only recognized for RSUs for which both the service condition and performance condition have been met. The service condition for these awards is generally satisfied over four years. The performance condition was satisfied upon the IPO. Prior to the IPO, the Company did not record expense on RSUs as a liquidity event upon which vesting is contingent was not probable of occurring. Following the closing of the IPO in December 2021, the Company began recording stock-based compensation expense for these RSUs using the accelerated attribution method, based on the grant-date fair value of the RSUs. RSUs granted after the IPO only have a service condition, and the related stock-based compensation expense is recognized on a straight-line basis over the requisite service period. The service condition for these awards is generally satisfied over four years for RSUs granted through fiscal year 2023 and either three or four years for RSUs granted after fiscal year 2023. A summary of the RSUs activity under the 2015 Plan and 2021 Plan during the nine months ended November 1, 2025 is presented below:
| Number of Shares |  | Weighted-Average Grant-Date Fair Value
Balance as of February 1, 2025 | 22,310,864 |  |  | $ | 23.14 |
Granted | 9,394,435 |  |  | $ | 35.91 |
Vested | (10,642,167) |  |  | $ | 22.28 |
Forfeited | (3,343,724) |  |  | $ | 26.05 |
Balance as of November 1, 2025 | 17,719,408 |  |  | $ | 29.88 |
As of November 1, 2025, unrecognized stock-based compensation expense related to outstanding unvested RSUs for employees that are expected to vest was approximately $491.3 million. The remaining unrecognized stock-based compensation expense is expected to be recognized over a weighted-average period of approximately 1.3 years. 2021 Employee Stock Purchase Plan—In December 2021, the Board of Directors adopted and stockholders approved the 2021 Employee Stock Purchase Plan (the “2021 ESPP”), which became effective in December 2021 in connection with the IP O. The total number of shares of the Company’s Class A common stock reserved for future issuance as of November 1, 2025 includes 5,657,192 shares added on the first day of fiscal year 2026 pursuant to the annual automatic evergreen increase provision of the 2021 ESPP. The price at which Class A common stock is purchased under the 2021 ESPP is equal to 85% of the lower of the fair market value of a share of the Company’s Class A common stock on the enrollment date or on the exercise date. The enrollment date means the first trading day of each offering period, and the exercise date means the last trading day of each purchase period. Offering periods are generally 12 months long, commencing on the first trading day on or after June 11 and December 11 of each year and terminating on the last trading day on or before June 10 and December 10 of each year. Purchase periods are generally six months long, commencing on the first trading day after one exercise date and ending with the next exercise date. For the nine months ended November 1, 2025 and November 2, 2024, 582,745 and 616,193 shares of Class A common stock were purchased under the 2021 ESPP, resulting in net cash proceeds of $18.7 million and $16.1 million, respectively. As of November 1, 2025, unrecognized stock-based compensation expense related to the 2021 ESPP was approximately $3.5 million. The remaining unrecognized stock-based compensation expense is expected to be recognized over a weighted-average period of approximately 0.5 years. Employee Stock Purchase Plan Valuation—The Company estimates the fair value of shares to be issued under the 2021 ESPP using the Black-Scholes option-pricing model. The Black-Scholes option-pricing model requires estimates of highly subjective assumptions, which greatly affect fair value. The weighted-average assumptions used to estimate the fair value of shares to be issued under the 2021 ESPP were as follows:
| Nine Months Ended
| November 1, 2025 |  | November 2, 2024 |  |
Expected volatility | 51.7% – 57.6% |  | 53.2% – 57.4% |  |
Expected term (years) | 0.5 – 1.0 |  | 0.5 – 1.0 |  |
Risk-free interest rate | 4.1% – 4.3% |  | 5.2% – 5.4% |  |
Expected dividend yield | 0.0% |  | 0.0% |  |
Expected volatility—The expected stock price volatility for the nine months ended November 1, 2025 and November 2, 2024 was based on the Company’s historical volatility for the expected term of the stock-based award. Expected term—The expected term is approximately 0.5 years for the first purchase period and approximately 1.0 year for the second purchase period. Risk-free interest rate—The risk-free interest rate assumption is based on observed U.S. Treasury yield curve interest rates in effect at the time of grant appropriate for the expected term of the stock-based award. Expected dividend yield—Because the Company has never paid and has no current intention to pay cash dividends on its common stock, the expected dividend yield is zero. Stock-Based Compensation Expense—Stock-based compensation expense, by grant type, was as follows (in thousands):
| Three Months Ended |  | Nine Months Ended
| November 1, 2025 |  | November 2, 2024 |  | November 1, 2025 |  | November 2, 2024 |  |
Stock options | $ | — |  |  | $ | 612 |  |  | $ | — |  |  | $ | 2,169 |  |  |
RSUs | 74,967 |  |  | 68,895 |  |  | 227,115 |  |  | 197,393 |  |  |
Employee stock purchase plan | 2,876 |  |  | 3,085 |  |  | 8,942 |  |  | 9,290 |  |  |
Total stock-based compensation expense | $ | 77,843 |  |  | $ | 72,592 |  |  | $ | 236,057 |  |  | $ | 208,852 |  |  |
Stock-based compensation expense included in the following line items of the Company’s condensed consolidated statements of operations and comprehensive income (loss) was as follows (in thousands):
| Three Months Ended |  | Nine Months Ended
| November 1, 2025 |  | November 2, 2024 |  | November 1, 2025 |  | November 2, 2024 |  |
Cost of revenue | $ | 3,553 |  |  | $ | 3,041 |  |  | $ | 10,420 |  |  | $ | 9,189 |  |  |
Research and development | 30,896 |  |  | 26,899 |  |  | 87,775 |  |  | 76,275 |  |  |
Sales and marketing | 20,541 |  |  | 22,008 |  |  | 67,925 |  |  | 61,886 |  |  |
General and administrative | 22,853 |  |  | 20,644 |  |  | 69,937 |  |  | 61,502 |  |  |
Total stock-based compensation expense | $ | 77,843 |  |  | $ | 72,592 |  |  | $ | 236,057 |  |  | $ | 208,852 |  |  |

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for equity. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8A -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/505/tableOfContent Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 16 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration